Literature DB >> 3411155

Complement enhancement of neutralizing antibody to the structural proteins of Chlamydia trachomatis.

D W Megran, H G Stiver, R Peeling, I W Maclean, R C Brunham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3411155     DOI： 10.1093/infdis/158.3.661

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.

Authors:  J S Lin; L L Yan; Y Ho; P A Rice
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).

Authors:  I S Barsoum; T A Goodman; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

Review 3.  A re-evaluation of the role of B cells in protective immunity to Chlamydia infection.

Authors:  Lin-Xi Li; Stephen J McSorley
Journal:  Immunol Lett       Date:  2015-02-20       Impact factor: 3.685

4.  Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2.

Authors:  R T Hall; T Strugnell; X Wu; D V Devine; H G Stiver
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Neutralization of Chlamydia trachomatis: kinetics and stoichiometry.

Authors:  R W Peeling; R C Brunham
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

6.  Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.

Authors:  Anja Weinreich Olsen; Emma Kathrine Lorenzen; Ida Rosenkrands; Frank Follmann; Peter Andersen
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 7.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

8.  A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Authors:  Anja Weinreich Olsen; Ida Rosenkrands; Martin J Holland; Peter Andersen; Frank Follmann
Journal:  NPJ Vaccines       Date:  2021-04-19       Impact factor: 9.399

9.  The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection.

Authors:  Ana Filipovic; Ehsan Ghasemian; Aleksandra Inic-Kanada; Ivana Lukic; Elisabeth Stein; Emilija Marinkovic; Radmila Djokic; Dejana Kosanovic; Nadine Schuerer; Hadeel Chalabi; Sandra Belij-Rammerstorfer; Marijana Stojanovic; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

10.  Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.

Authors:  Jeanette Erbo Wern; Maria Rathmann Sorensen; Anja Weinreich Olsen; Peter Andersen; Frank Follmann
Journal:  Front Immunol       Date:  2017-05-17       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.